CymaBay Therapeutics Inc (NASDAQ:CBAY)

14.73
BATS BZX Real-Time Price
As of 11:23am ET
 +0.125 / +0.86%
Today’s Change
3.16
Today|||52-Week Range
18.20
+134.93%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$1.8B

Company Description

CymaBay Therapeutics, Inc. engages in the provision and development of access to therapies for patients with liver and other chronic diseases with high unmet medical needs. Its products pipeline includes Seladelpar, MBX-2982, CB-0406, and CB-001. The company was founded on October 5, 1988 and is headquartered in Newark, CA.

Contact Information

CymaBay Therapeutics, Inc.
7575 Gateway Boulevard
Newark California 94560
P:(510) 293-8800
Investor Relations:

Employees

Shareholders

Other institutional51.99%
Mutual fund holders26.60%
Individual stakeholders11.15%

Top Executives

Sujal ShahPresident, Chief Executive Officer & Director
Harish ShantharamChief Financial Officer
Charles A. McWherterPresident-Research & Development
Paul T. QuinlanSecretary & Chief Compliance Officer
Patrick J. O'MaraSenior Vice President-Business Development